Choksi Laboratories Limited has announced the resignation of Mrs. Meenaxi Patidar from her position as Non-Executive Independent Director, effective January 09, 2026. The resignation was communicated to the Bombay Stock Exchange on January 10, 2026, in compliance with regulatory requirements.

Resignation Details

Mrs. Patidar, who holds Director Identification Number (DIN) 10206356, submitted her resignation via email on January 09, 2026. She cited preoccupation and personal commitments as the primary reasons for stepping down from her directorial role.

Impact on Board Committees

Following her resignation as Independent Director, Mrs. Patidar has also ceased her involvement in key board committees. She was serving as a Member of the Audit Committee and held the position of Chairperson of the Nomination & Remuneration Committee.

The departure creates vacancies in these critical governance committees that will need to be addressed by the company's board of directors in due course.

Regulatory Compliance

Choksi Laboratories Limited has fulfilled all mandatory disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required by the SEBI Master Circular dated November 11, 2024.

Director's Confirmation

In her resignation letter addressed to the Board of Directors, Mrs. Patidar expressed gratitude for the trust and support received during her tenure. She specifically confirmed that there are no other material reasons for her resignation beyond the preoccupation and personal commitments mentioned in her letter.

The resignation was processed by Company Secretary and Compliance Officer Prakhar Dubey, who signed the regulatory filing on January 10, 2026. Mrs. Patidar wished the company continued success and prosperity in her farewell message to the board and company members.

Choksi Laboratories Limited, a prominent player in the laboratory services sector, has announced the reappointment of Mr. Vyangesh Choksi as Whole Time Director for an extended five-year term. The decision, made during a board meeting on August 13, 2025, is subject to shareholder approval at the upcoming General Meeting.

Key Details of the Reappointment

• Term: Mr. Choksi's new term will run from September 1, 2025, to August 31, 2030.
• Approval Process: The reappointment was recommended by the Nomination and Remuneration Committee and approved by the Board of Directors.
• Shareholder Approval: The decision is pending ratification at the forthcoming General Meeting.

About Vyangesh Choksi

Mr. Vyangesh Choksi is a promoter member of Choksi Laboratories Limited with extensive experience in management and administration. His reappointment underscores the company's confidence in his leadership and vision.

Family Ties in Management

The reappointment highlights the strong family presence in Choksi Laboratories' top management:

• Sunil Choksi: Managing Director (Father of Vyangesh Choksi)
• Stela Choksi: Whole Time Director (Mother)
• Himika Choksi: Whole Time Director (Sister)

Other Board Decisions

In the same board meeting, Choksi Laboratories Limited made several other significant decisions:

1. Financial Results: Approved the unaudited standalone financial results for the quarter ended June 30, 2025.
2. Annual General Meeting: Set the date for the 32nd Annual General Meeting (AGM) for September 16, 2025, to be held via video conferencing.
3. Auditor Appointments:
   • Appointed M/s Surabhi Agrawal & Associates as Secretarial Auditor for a five-year term (FY 2025-2026 to FY 2029-2030).
   • Reappointed M/s Tanmay V. Rajurkar & Co. as Internal Auditor for FY 2025-26.

Conclusion

The reappointment of Vyangesh Choksi as Whole Time Director for another five-year term reflects Choksi Laboratories' commitment to maintaining stable leadership. This continuity in management is expected to play a crucial role in the company's future strategies and operations within the laboratory services sector.